2. News
  3. Beckman Coulter
     Page  1 2 3  ... Next 
Beckman Coulter acquires artificial intelligence company providing evidence-based clinical decision support for emergency departments27 Oct 2022
Beckman Coulter and Scopio Labs partner to accelerate adoption of hematology digital cell morphology platform28 Jul 2022
Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis21 Jun 2022
Beckman Coulter achieves CE Mark for its MDW-SARS CoV-2 application as an aid in identifying patients with risk of COVID-1922 Mar 2022
Beckman Coulter introduces antipsychotic drug testing to address unmet clinical need for people living with serious mental conditions15 Mar 2022
Beckman Coulter launches Access AMH Advanced, an innovative test for clinicians to better personalize IVF treatments8 Jun 2021
Beckman Coulter launches a fully automated COVID-19 IgG test to assess antibody immune response levels20 May 2021
Beckman Coulter is first diagnostics company to offer workflow automation specifically for mid-volume laboratories5 May 2021
Beckman Coulter offers $4/high-throughput antigen test to support U.S. government initiative to expand COVID-19 testing25 Mar 2021
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA25 Mar 2021